Pharmafile Logo
Pharmafocus logo
Advanced Search

market access

Showing 15 posts of 53 posts found.

image

Market access: please, no more talk of ‘hurdles’ and ‘obstacles’

February 7, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing barr, market access, pm society

For the UK pharmaceutical industry, biotech or devices firms, any discussion around market access tends to be synonymous with ‘hurdles’ …

Feature

Innovation scorecard gets ABPI thumbs-up

August 29, 2012
Sales and Marketing NHS, NICE, market access

 An NHS ‘innovation scorecard’, showing which hospitals in England are using NICE-approved drugs – and which aren’t – has been …

News
Rawlins image

Sue NHS to ensure access to drugs, says NICE chief

August 6, 2012
Lucentis, NICE, Ozurdex, judicial review, market access, ophthamology

 The chairman of NICE is advising campaigners to sue NHS bodies that block a treatment recommended by the watchdog.In a …

News

Health Economics and Outcomes Research – What’s the Value?

July 2, 2012
Medical Communications HEOR, clinical evidence, economic evidence, market access, value

Pricing pressure and regulatory restrictions across various healthcare industries have called for more detailed evidence of outcomes

Feature
Thought Leadership

Measuring Return on Investment of Health Economics and Outcomes Research through the Cloud

July 2, 2012
Medical Communications HEOR, ROI, interactive tools, market access

Health economics and outcomes research (HEOR) is a young and fascinating area of research with an engaged academic community. Methodology …

Feature
Thought Leadership

The European Medicines Group: focused on UK market access

June 25, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMG, NICE, VBP, market access

Maintaining a dialogue with government, NHS organisations and other stakeholder groups is essential for pharma companies in the UK, and …

Feature

Global marketing access strategy: local activation

June 6, 2012
Business Services, Medical Communications, Sales and Marketing Global marketing, MSI, market access

Pharma has historically been an industry that likes to put things in boxes, neatly organising different aspects of commercialisation into …

Feature
oliver_leatham

MSI appoints new market access consultant

May 22, 2012
Business Services, Medical Communications, Research and Development, Sales and Marketing MSI Consultancy, appointment, market access

Strategic marketing firm The MSI Consultancy has appointed Oliver Leatham as market access consultant. Oliver has a wide experience as …

Appointment

Capturing the Brazilian pharma opportunity

May 16, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brazil, McKinsey, market access, middle class, pharma

 Many multinationals are hungry to sell their goods and services to the emerging markets’ growing middle class, comprising nearly two …

Feature
Lucentis image

Novartis ponders Lucentis price cut in UK

May 8, 2012
Medical Communications, Sales and Marketing Lucentis, NICE, avastin, market access

 Novartis could cut the price of its eye drug Lucentis in the UK to head off moves to switch patients …

News

Market access and the new consortia

July 14, 2011
Sales and Marketing GP consortia, NHS reform, market access

The National Health Service in England is undergoing massive structural and financial upheaval, and pharma marketers will be rightly concerned …

Feature

Integrate: marketing and market access must come together

April 28, 2011
Sales and Marketing Drug pricing, market access, marketing

Although the words ‘market access’ have become much more commonplace in our working lives, the new clarity of its importance …

Feature

Valuing medicines and NHS reform – the ABPI view

December 10, 2010
Sales and Marketing ABPI, NHS reforms, Paul Catchpole, market access, value-based pricing

For those concerned with improving the value for money of medicines to the UK’s health service, the government’s White Paper …

Feature

Working with a changing NHS

August 2, 2010
Sales and Marketing HCA, NHS, commissioning, market access

The first Healthcare Communications Association (HCA) forum of 2010 took place this April in London and looked at the central …

Feature

UK lags behind Europe on innovative cancer drugs

July 29, 2010
Sales and Marketing Cancer, market access

The UK has been ranked as one of the worst countries when it comes to uptake of new cancer drug …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026